DaVita Inc. (DVA)
NYSE: DVA · IEX Real-Time Price · USD
134.45
-7.79 (-5.48%)
At close: May 3, 2024, 4:00 PM
134.16
-0.29 (-0.22%)
After-hours: May 3, 2024, 7:33 PM EDT
DaVita Employees
DaVita had 70,000 employees on December 31, 2023. The number of employees did not change compared to the previous year.
Employees
70,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$176,257
Profits / Employee
$11,652
Market Cap
11.79B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 70,000 | 0 | - |
Dec 31, 2022 | 70,000 | 1,000 | 1.45% |
Dec 31, 2021 | 69,000 | 2,000 | 2.99% |
Dec 31, 2020 | 67,000 | 2,000 | 3.08% |
Dec 31, 2019 | 65,000 | -12,700 | -16.34% |
Dec 31, 2018 | 77,700 | 3,200 | 4.30% |
Dec 31, 2017 | 74,500 | 4,200 | 5.97% |
Dec 31, 2016 | 70,300 | 9,900 | 16.39% |
Dec 31, 2015 | 60,400 | 2,500 | 4.32% |
Dec 31, 2014 | 57,900 | 500 | 0.87% |
Dec 31, 2013 | 57,400 | 4,000 | 7.49% |
Dec 31, 2012 | 53,400 | 12,400 | 30.24% |
Dec 31, 2011 | 41,000 | 4,500 | 12.33% |
Dec 31, 2010 | 36,500 | 2,500 | 7.35% |
Dec 31, 2009 | 34,000 | 1,500 | 4.62% |
Dec 31, 2008 | 32,500 | 1,500 | 4.84% |
Dec 31, 2007 | 31,000 | 2,100 | 7.27% |
Dec 31, 2006 | 28,900 | 900 | 3.21% |
Dec 31, 2005 | 28,000 | 12,700 | 83.01% |
Dec 31, 2004 | 15,300 | 1,500 | 10.87% |
Dec 31, 2003 | 13,800 | 800 | 6.15% |
Dec 31, 2002 | 13,000 | 300 | 2.36% |
Dec 31, 2001 | 12,700 | 500 | 4.10% |
Dec 31, 2000 | 12,200 | -100 | -0.81% |
Dec 31, 1999 | 12,300 | 0 | - |
Dec 31, 1998 | 12,300 | 3,470 | 39.30% |
Dec 31, 1997 | 8,830 | 5,705 | 182.56% |
Dec 31, 1996 | 3,125 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG & Co. KGaA | 119,845 |
Dr. Reddy's Laboratories | 25,863 |
Charles River Laboratories International | 21,800 |
Medpace Holdings | 5,900 |
Insulet | 3,000 |
Incyte | 2,524 |
ShockWave Medical | 1,468 |
Sarepta Therapeutics | 1,314 |
DVA News
- 1 day ago - DaVita gains after upbeat quarterly profit prompts annual forecast raise - Reuters
- 1 day ago - DaVita Inc. 1st Quarter 2024 Results - PRNewsWire
- 9 days ago - Best blue chip healthcare stocks to buy and hold in 2024 - Invezz
- 11 days ago - DaVita's Global Operations Powered by 100% Renewable Energy - PRNewsWire
- 16 days ago - DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call - PRNewsWire
- 23 days ago - DaVita Announces Dennis Pullin to its Board of Directors - PRNewsWire
- 7 weeks ago - The American Diabetes Association and DaVita Strengthen Alliance to Tackle Chronic Disease Head-On - PRNewsWire
- 2 months ago - DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024 - PRNewsWire